Skip to main content

Advertisement

SpringerLink
Log in

Involvement of osteopontin as a core protein in craniopharyngioma calcification formation

  • Laboratory Investigation - Human/Animal Tissue
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Matrix proteins are considered to be essential for biomineralization and to be important factors in cranioharyngioma calcification. Osteopontin (OPN) is a noncollagenous, acidic bone-matrix glycoprotein, which binds tightly to hydroxyapatite and appears to form an integral part of the mineralized matrix, probably important to the integrity of cell–matrix interactions. OPN is also a ligand for a cell membrane receptor, CD44v6, which is required for efficient OPN binding. To investigate the role of OPN in craniopharyngioma calcification formation, we studied the involvement of OPN and CD44v6 in craniopharyngiomas. Immunohistochemical staining was used in human craniopharyngiomas to detect the relationship of OPN and degree of calcification, and immunogold localization of OPN was done to identify cell secretory granules. OPN expression was elevated in calcification craniopharyngioma samples. Immunohistochemical staining demonstrated that the OPN expression level was significantly correlated with the degree of calcification (χ2 = 29.987, P < 0.001); meanwhile, immunoelectron microscopy revealed subcellular sites of OPN presenting in epithelial cells, suggesting that the OPN protein is probably synthesized and secreted by stellate reticulum-like cells and ameloblast-like cells. At the same time, OPN expression was paralleled by cell surface reactivity for CD44v6, an OPN functional receptor. These results suggest that OPN is possibly involved as a core protein in the formation of craniopharyngioma calcification.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547–551

    Article  CAS  PubMed  Google Scholar 

  2. Garnett MR, Puget S, Grill J, Sainte-Rose C (2007) Craniopharyngioma. Orphanet J Rare Dis 2:18

    Article  PubMed  Google Scholar 

  3. Rekate HL (2005) Craniopharyngioma. J Neurosurg 103:297–298 discussion 298

    PubMed  Google Scholar 

  4. Wisoff JH (2008) Craniopharyngioma. J Neurosurg Pediatr 1:124–125 discussion 125

    Article  PubMed  Google Scholar 

  5. Crotty TB, Scheithauer BW, Young WF Jr, Davis DH, Shaw EG, Miller GM, Burger PC (1995) Papillary craniopharyngioma: a clinicopathological study of 48 cases. J Neurosurg 83:206–214

    Article  CAS  PubMed  Google Scholar 

  6. Eldevik OP, Blaivas M, Gabrielsen TO, Hald JK, Chandler WF (1996) Craniopharyngioma: radiologic and histologic findings and recurrence. AJNR Am J Neuroradiol 17:1427–1439

    CAS  PubMed  Google Scholar 

  7. Fisher PG, Jenab J, Gopldthwaite PT, Tihan T, Wharam MD, Foer DR, Burger PC (1998) Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst 14:558–563

    Article  CAS  PubMed  Google Scholar 

  8. Miller DC (1994) Pathology of craniopharyngiomas: clinical import of pathological findings. Pediatr Neurosurg 21(Suppl 1):11–17

    Article  PubMed  Google Scholar 

  9. Tsuda M, Takahashi S, Higano S, Kurihara N, Ikeda H, Sakamoto K (1997) CT and MR imaging of craniopharyngioma. Eur Radiol 7:464–469

    Article  CAS  PubMed  Google Scholar 

  10. Sato K, Kubota T (1999) Fine structure of ossification in craniopharyngiomas. Ultrastruct Pathol 23:395–399

    Article  CAS  PubMed  Google Scholar 

  11. Sato K, Kubota T, Yamamoto S, Ishikura A (1986) An ultrastructural study of mineralization in craniopharyngiomas. J Neuropathol Exp Neurol 45:463–470

    Article  CAS  PubMed  Google Scholar 

  12. Vilches J, Lopez A, Martinez MC, Gomez J, Barbera J (1981) Scanning and transmission electron microscopy of a craniopharyngioma: x-ray microanalytical study of the intratumoral mineralized deposits. Ultrastruct Pathol 2:343–356

    Article  CAS  PubMed  Google Scholar 

  13. Yoshimoto M, de Toledo SR, da Silva NS, Bayani J, Bertozzi AP, Stavale JN, Cavalheiro S, Andrade JA, Zielenska M, Squire JA (2004) Comparative genomic hybridization analysis of pediatric adamantinomatous craniopharyngiomas and a review of the literature. J Neurosurg 101:85–90

    PubMed  Google Scholar 

  14. Diao H, Kon S, Iwabuchi K, Kimura C, Morimoto J, Ito D, Segawa T, Maeda M, Hamuro J, Nakayama T, Taniguchi M, Yagita H, Van Kaer L, Onoe K, Denhardt D, Rittling S, Uede T (2004) Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21:539–550

    Article  CAS  PubMed  Google Scholar 

  15. Furger KA, Menon RK, Tuck AB, Bramwell VH, Chambers AF (2001) The functional and clinical roles of osteopontin in cancer and metastasis. Curr Mol Med 1:621–632

    Article  CAS  PubMed  Google Scholar 

  16. Haylock DN, Nilsson SK (2006) Osteopontin: a bridge between bone and blood. Br J Haematol 134:467–474

    Article  CAS  PubMed  Google Scholar 

  17. O’Regan A, Berman JS (2000) Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation. Int J Exp Pathol 81:373–390

    Article  PubMed  Google Scholar 

  18. Prince CW, Butler WT (1987) 1, 25-Dihydroxyvitamin D3 regulates the biosynthesis of osteopontin, a bone-derived cell attachment protein, in clonal osteoblast-like osteosarcoma cells. Coll Relat Res 7:305–313

    CAS  PubMed  Google Scholar 

  19. Rangaswami H, Bulbule A, Kundu GC (2006) Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 16:79–87

    Article  CAS  PubMed  Google Scholar 

  20. Shinohara ML, Jansson M, Hwang ES, Werneck MB, Glimcher LH, Cantor H (2005) T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc Natl Acad Sci USA 102:17101–17106

    Article  CAS  PubMed  Google Scholar 

  21. Shinohara ML, Lu L, Bu J, Werneck MB, Kobayashi KS, Glimcher LH, Cantor H (2006) Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 7:498–506

    Article  CAS  PubMed  Google Scholar 

  22. Weber GF (2001) The metastasis gene osteopontin: a candidate target for cancer therapy. Biochim Biophys Acta 1552:61–85

    CAS  PubMed  Google Scholar 

  23. Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR (1992) Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 3:1169–1180

    CAS  PubMed  Google Scholar 

  24. Chen Y, Bal BS, Gorski JP (1992) Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem 267:24871–24878

    CAS  PubMed  Google Scholar 

  25. Rittling SR, Chambers AF (2004) Role of osteopontin in tumour progression. Br J Cancer 90:1877–1881

    Article  CAS  PubMed  Google Scholar 

  26. Weber GF, Ashkar S, Cantor H (1997) Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc Assoc Am Physicians 109:1–9

    CAS  PubMed  Google Scholar 

  27. Ponta H, Sherman L, Herrlich PA (2003) CD44: from adhesion molecules to signalling regulators. Nat Rev Mol Cell Biol 4:33–45

    Article  CAS  PubMed  Google Scholar 

  28. Ermak G, Gerasimov G, Troshina K, Jennings T, Robinson L, Ross JS, Figge J (1995) Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid. Cancer Res 55:4594–4598

    CAS  PubMed  Google Scholar 

  29. Ermak G, Jennings T, Robinson L, Ross JS, Figge J (1996) Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma. Cancer Res 56:1037–1042

    CAS  PubMed  Google Scholar 

  30. Chhieng DC, Ross JS, McKenna BJ (1997) CD44 immunostaining of thyroid fine-needle aspirates differentiates thyroid papillary carcinoma from other lesions with nuclear grooves and inclusions. Cancer 81:157–162

    Article  CAS  PubMed  Google Scholar 

  31. Lee JL, Wang MJ, Sudhir PR, Chen GD, Chi CW, Chen JY (2007) Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Cancer Res 67:2089–2097

    Article  CAS  PubMed  Google Scholar 

  32. Matsubara A, Laake JH, Davanger S, Usami S, Ottersen OP (1996) Organization of AMPA receptor subunits at a glutamate synapse: a quantitative immunogold analysis of hair cell synapses in the rat organ of Corti. J Neurosci 16:4457–4467

    CAS  PubMed  Google Scholar 

  33. Akagi T, Ishida K, Hanasaka T, Hayashi S, Watanabe M, Hashikawa T, Tohyama K (2006) Improved methods for ultracryotomy of CNS tissue for ultrastructural and immunogold analyses. J Neurosci Methods 153:276–282

    Article  PubMed  Google Scholar 

  34. Senger DR, Perruzzi CA, Gracey CF, Papadopoulos A, Tenen DG (1988) Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res 48:5770–5774

    CAS  PubMed  Google Scholar 

  35. Franzen A, Heinegard D (1985) Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 232:715–724

    CAS  PubMed  Google Scholar 

  36. Nagata T, Bellows CG, Kasugai S, Butler WT, Sodek J (1991) Biosynthesis of bone proteins [SPP-1 (secreted phosphoprotein-1, osteopontin), BSP (bone sialoprotein) and SPARC (osteonectin)] in association with mineralized-tissue formation by fetal-rat calvarial cells in culture. Biochem J 274(Pt 2):513–520

    CAS  PubMed  Google Scholar 

  37. Nagata T, Yokota M, Ohishi K, Nishikawa S, Shinohara H, Wakano Y, Ishida H (1994) 1 alpha, 25-dihydroxyvitamin D3 stimulation of osteopontin expression in rat clonal dental pulp cells. Arch Oral Biol 39:775–782

    Article  CAS  PubMed  Google Scholar 

  38. Mohler ER III, Adam LP, McClelland P, Graham L, Hathaway DR (1997) Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 17:547–552

    PubMed  Google Scholar 

  39. Steitz SA, Speer MY, McKee MD, Liaw L, Almeida M, Yang H, Giachelli CM (2002) Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol 161:2035–2046

    CAS  PubMed  Google Scholar 

  40. Heinegard D, Andersson G, Reinholt FP (1995) Roles of osteopontin in bone remodeling. Ann N Y Acad Sci 760:213–222

    Article  CAS  PubMed  Google Scholar 

  41. Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin-Zallone A, Ross FP, Teitelbaum SL, Cheresh D et al (1993) Binding of osteopontin to the osteoclast integrin alpha v beta 3. Osteoporos Int 3(Suppl 1):132–135

    Article  PubMed  Google Scholar 

  42. Denhardt DT, Noda M (1998) Osteopontin expression and function: role in bone remodeling. J Cell Biochem (Suppl 30–31):92–102

    Article  PubMed  Google Scholar 

  43. Wada T, McKee MD, Steitz S, Giachelli CM (1999) Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin. Circ Res 84:166–178

    CAS  PubMed  Google Scholar 

  44. Bellahcene A, Castronovo V (1995) Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Am J Pathol 146:95–100

    CAS  PubMed  Google Scholar 

  45. Hirota S, Ito A, Nagoshi J, Takeda M, Kurata A, Takatsuka Y, Kohri K, Nomura S, Kitamura Y (1995) Expression of bone matrix protein messenger ribonucleic acids in human breast cancers. Possible involvement of osteopontin in development of calcifying foci. Lab Invest 72:64–69

    CAS  PubMed  Google Scholar 

  46. Maki M, Hirota S, Kaneko Y, Morohoshi T (2000) Expression of osteopontin messenger RNA by macrophages in ovarian serous papillary cystadenocarcinoma: a possible association with calcification of psammoma bodies. Pathol Int 50:531–535

    Article  CAS  PubMed  Google Scholar 

  47. Rodrigues LR, Teixeira JA, Schmitt FL, Paulsson M, Lindmark-Mansson H (2007) The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomarkers Prev 16:1087–1097

    Article  CAS  PubMed  Google Scholar 

  48. Liszczak T, Richardson EP Jr, Phillips JP, Jacobson S, Kornblith PL (1978) Morphological, biochemical, ultrastructural, tissue culture and clinical observations of typical and aggressive craniopharyngiomas. Acta Neuropathol 43:191–203

    CAS  PubMed  Google Scholar 

  49. Matusan-Ilijas K, Behrem S, Jonjic N, Zarkovic K, Lucin K (2008) Osteopontin expression correlates with angiogenesis and survival in malignant astrocytoma. Pathol Oncol Res 14:293–298

    Article  PubMed  Google Scholar 

  50. Ding Q, Stewart J Jr, Prince CW, Chang PL, Trikha M, Han X, Grammer JR, Gladson CL (2002) Promotion of malignant astrocytoma cell migration by osteopontin expressed in the normal brain: differences in integrin signaling during cell adhesion to osteopontin versus vitronectin. Cancer Res 62:5336–5343

    CAS  PubMed  Google Scholar 

  51. Jang T, Savarese T, Low HP, Kim S, Vogel H, Lapointe D, Duong T, Litofsky NS, Weimann JM, Ross AH, Recht L (2006) Osteopontin expression in intratumoral astrocytes marks tumor progression in gliomas induced by prenatal exposure to N-ethyl-N-nitrosourea. Am J Pathol 168:1676–1685

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was partially supported by the Research Center of Clinical Medicine, Nanfang Hospital, Southern Medical University, China.

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, The People’s Republic of China

    Qi SongTao, Huang GuangLong, Pan Jun, Zhang Xi’An, Fang LuXiong, Liu BaoGuo, Meng Wei, Zhang YongMing & Liu XiaoJun

  2. Department of Endocrine and Metabolism, Nanfang Hospital, Southern Medical University, Guangzhou, The People’s Republic of China

    Li Jia

Authors
  1. Qi SongTao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Huang GuangLong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pan Jun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Li Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhang Xi’An
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Fang LuXiong
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Liu BaoGuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Meng Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zhang YongMing
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Liu XiaoJun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qi SongTao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

SongTao, Q., GuangLong, H., Jun, P. et al. Involvement of osteopontin as a core protein in craniopharyngioma calcification formation. J Neurooncol 98, 21–30 (2010). https://doi.org/10.1007/s11060-009-0053-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-009-0053-8

Keywords

Search

Navigation